阿裏(09988.HK)與巴西出口投資促進局簽署諒解備忘錄
阿裏-SW(09988.HK)與巴西出口投資促進局(ApexBrasil)於9月3日的中國國際服務貿易會期間,簽署諒解備忘錄。
在諒解備忘錄框架下,阿裏巴巴國際站上開設「巴西製造」專屬國家館,篩選出當地100家有電商經驗的企業,由巴西出口投資促進局提供補貼,獲得扶持入駐的機會。阿裏巴巴國際站則提供營運方面的專屬服務,以及定製化巴西出口的B2B分銷服務。雙方亦達成意向,將在巴西共同推進數字經濟培訓項目。
去年巴西電商銷售增長35%,其中巴西商家通過阿裏巴巴旗下電商平臺在中國的銷售額達到2.53億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.